(:TRXC)

Business Focus: N/A

Mar 05, 2021 06:55 am ET

Asensus Surgical Announces Finalization of Name and Ticker Symbol Change

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the formal completion of its previously announced name and ticker symbol change.

Mar 04, 2021 06:55 am ET

Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes on T

Mar 03, 2021 06:55 am ET

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expans

Mar 01, 2021 06:55 am ET

Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Fi

Feb 23, 2021 10:53 am ET

TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery

Asensus Surgical's technology platform, Senhance® Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform). Today, the Senhance Surgical System is being used by over 100 a

Feb 18, 2021 08:45 am ET

TransEnterix Announces New Training Center in EU

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff throughout Europe with basic and advanced training on the Senhance® Surgical System. The ASC will also provide TransEnterix with a world-class facility to engage European surgeons in technology and clinical development studies.

Feb 11, 2021 07:30 am ET

Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027

Palm Beach, Fl., Feb. 11, 2021 /PRNewswire/ -- Cardiovascular devices are the medical devices which are used to diagnosis and treat the heart diseases and other heart-related problems. These devices play essential role prevention and treatment of cardiovascular diseases. The cardiovascular devices include implantable cardioverter defibrillators, implanted heart rhythm monitors, pacemakers, and various other devices. The cardiovascular devices market is currently witnessing considerable demand across the globe. Increasing awareness about the various cardiovascular diseases and increasing ger

Feb 10, 2021 06:55 am ET

TransEnterix to Host Virtual Investor Day on February 23, 2021

Feb 01, 2021 04:05 pm ET

TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock. Including the full exercise of the underwriter’s option to purchase additional shares, the Company issued 26,545,832 shares at a public offering price of $3.00 per share. The aggregate gross proceeds from this offering is approximately $79.64 million, before deducting underwriting discounts and commissions and offering

Jan 26, 2021 10:57 pm ET

TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of $3.00 per share, less underwriting discounts and commissions. The Company also has granted the underwriter a 30-day option to purchase up to an additi

Jan 26, 2021 04:58 pm ET

TransEnterix Announces $25.0 Million Bought Deal Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 8,333,334 shares of common stock of the Company at a public offering price of $3.00 per share, less underwriting discounts and commissions. The Company also has granted the underwriter a 30-day option to purchase up to

Jan 19, 2021 06:55 am ET

TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical UnitTM (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System. This approval will provide Senhance digital laparoscopic programs in Europe access to this new technology, ushering them to the forefront of surgical innovation utilizing augmented intelligence.

Jan 14, 2021 02:23 pm ET

TransEnterix Announces Closing of $31.25 Million Registered Direct Offering of Common Stock

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced registered direct offering of 25,000,000 shares of its common stock. The offering was priced at a purchase price per share of $1.25, for gross proceeds of approximately $31.25 million.

Jan 12, 2021 07:50 am ET

TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a registered direct offering of 25,000,000 shares of its common stock at a purchase price of $1.25 per share for gross proceeds of $31.25 million. The offering is expected to close on or about January 14, 2021, subject to satisfaction of customary closing conditions.

Jan 11, 2021 09:55 am ET

Thinking about buying stock in Sundial Growers, Acasti Pharma, Transenterix, Jaguar Health, or Marathon Patent Group?

NEW YORK, Jan. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, ACST, TRXC, JAGX, and MARA.

Jan 11, 2021 07:30 am ET

Thinking about buying stock in Nio, Zomedica, Transenterix, Aileron Therapeutics, or BioNano Genomics?

NEW YORK, Jan. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, ZOM, TRXC, ALRN, and BNGO.

Jan 06, 2021 06:50 am ET

TransEnterix Provides Preliminary 2020 Year-End Corporate Update

Jan 05, 2021 09:50 am ET

Thinking about buying stock in BioNano Genomics, Ocugen, Acasti Pharma, Novan, or Transenterix?

NEW YORK, Jan. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, ACST, NOVN, and TRXC.

Jan 04, 2021 06:55 am ET

TransEnterix to Participate in Two Upcoming Virtual Healthcare Conferences

TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at two upcoming virtual investor conferences:

Dec 17, 2020 06:50 am ET

TransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic Program

Dec 16, 2020 08:00 am ET

TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance® Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation.

Nov 05, 2020 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020

Nov 03, 2020 06:55 am ET

TransEnterix to Present at the Stifel 2020 Virtual Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the Stifel 2020 Virtual Healthcare Conference. The virtual presentation is scheduled to take place at 4:00 pm Eastern Time, Tuesday, November 17, 2020.

Oct 26, 2020 06:55 am ET

TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Thursday, November 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Oct 13, 2020 06:55 am ET

TransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that surgeons at Maastricht University Medical Center+ (MUMC+) in the Netherlands, have successfully operated on multiple pediatric patients, becoming the first pediatric surgical program in the world to utilize the Senhance® Surgical System and integrate digital laparoscopy with instruments as small as 3 mm into their standard of surgical care.

Oct 07, 2020 06:55 am ET

TransEnterix Announces Toshima Hospital in Japan to Initiate a Senhance® Digital Laparoscopy Program

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Toshima Hospital of the Tokyo Metropolitan Health and Hospitals Corporation has entered into an agreement to lease and utilize a Senhance® Surgical System.

Sep 23, 2020 06:55 am ET

TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Hackensack Meridian Health Pascack Valley Medical Center, a hospital in New Jersey, successfully completed its first surgical procedures using the Intelligent Surgical UnitTM (ISU™). The technology previously received FDA clearance, and currently enables machine vision capabilities on the SenhanceⓇ Surgical System. The patients were treated by Dr. Amit Trivedi, Chair of Surgery at

Sep 14, 2020 06:55 am ET

TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International Medical Center in the Greater Tokyo Area.

Sep 08, 2020 04:05 pm ET

TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference. The presentation is scheduled to take place virtually at 3:00 PM Eastern, Tuesday, September 15, 2020.

Aug 25, 2020 06:15 pm ET

TransEnterix Announces New Employment Inducement Grant

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that in connection with the appointment of Shameze Rampertab as the Company’s Executive Vice President and Chief Financial Officer effective August 24, 2020, the Compensation Committee of the Company’s Board of Directors granted the following inducement grants to Mr. Rampertab:

Aug 13, 2020 06:55 am ET

TransEnterix Announces Appointment of Shameze Rampertab as Chief Financial Officer

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Shameze Rampertab has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective August 24, 2020.

Aug 05, 2020 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2020

Aug 04, 2020 06:55 am ET

TransEnterix Announces Submission of General Surgery Expansion in the US

Jul 27, 2020 06:50 am ET

TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Maastricht University Medical Center+ (MUMC+) has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first hospital to acquire a Senhance to be utilized in pediatric minimally invasive surgery.

Jul 22, 2020 06:55 am ET

TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Jul 06, 2020 04:05 pm ET

TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering, with total gross proceeds of approximately $15.0 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares, prior to deducting underwriting discounts and commissions and offering expenses payable by TransEnterix.

Jul 01, 2020 08:30 am ET

TransEnterix Announces Pricing of $13.0 Million Underwritten Public Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced underwritten offering of common stock, comprised of 37,267,080 shares of common stock at a public offering price of $0.35 per share, resulting in gross proceeds of approximately $13.0 million, before deducting underwriter discounts and commissions and expenses payable by the Company.

Jun 30, 2020 04:15 pm ET

TransEnterix Announces Launch of Underwritten Public Offering of Common Stock

Jun 23, 2020 06:55 am ET

TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Sana Klinikum Offenbach has entered into an agreement to lease and utilize a Senhance® Surgical System. Located in the city of Offenbach am Main, the hospital is located close to Frankfurt and serves patients in the large Rhine-Main region of Germany.

May 21, 2020 06:55 am ET

TransEnterix Announces Sinai Health System in Chicago to Initiate Program with the Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Sinai Health System in Chicago has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first facility in Chicago to move in this direction.

May 14, 2020 06:55 am ET

TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2020

May 05, 2020 06:55 am ET

TransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2020

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release first quarter financial and operating results before the market opens on Thursday, May 14, 2020. The Company will host a conference call to discuss these results starting at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.

Mar 16, 2020 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2019

Mar 13, 2020 06:55 am ET

TransEnterix Receives FDA Clearance for First Machine Vision System in Robotic Surgery

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received 510(k) clearance for the Intelligent Surgical Unit (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System.

Mar 09, 2020 06:55 am ET

TransEnterix Schedules Fourth Quarter and Fiscal Year 2019 Financial and Operating Results Conference Call for March 16, 2020

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter financial and Fiscal year 2019 operating results after the market closes on Monday, March 16, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Mar 06, 2020 08:15 am ET

TransEnterix Announces Pricing of $15 Million Underwritten Public Offering

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced underwritten offering of units. The offering was comprised of (i) units of common stock and warrants to purchase shares of common stock and (ii) units of convertible preferred stock and warrants to purchase shares of common stock.

Mar 05, 2020 04:15 pm ET

TransEnterix Announces Launch of Underwritten Public Offering

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has commenced an underwritten offering of units. The offering is expected to be comprised of (i) a unit of common stock and warrants to purchase shares of common stock and (ii) a unit of convertible preferred stock and warrants to purchase shares of common stock. The unit of convertible preferred stock and warrants is being offered in lieu of the unit of common stock and warrants for those purchase

Mar 02, 2020 06:45 am ET

TransEnterix Announces St. Marianna University School of Medicine Toyoko Hospital in Japan to Initiate a Senhance Digital Laparoscopy Program

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the St. Marianna University School of Medicine Toyoko Hospital, a hospital in the greater Tokyo metropolitan area, has entered into an agreement to lease and utilize a Senhance® Surgical System.

Feb 28, 2020 06:55 am ET

TransEnterix Announces Kitakyushu General Hospital Completes First Surgical Procedures with the Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Kitakyushu General Hospital, a hospital in southwestern Japan, completed its first surgical procedures using the Senhance® Surgical System. The first patients were treated by Dr. Naoki Nagata, President of Kitakyushu General Hospital, and team across general and colorectal minimally invasive surgical procedures. TransEnterix had announced on January 29, 2020 that Kitakyushu General Hospi

Feb 12, 2020 06:50 am ET

TransEnterix Announces CE Mark Approval for Pediatric Indication for Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for an expanded indication to treat pediatric patients above 10kg (approximately 22 lbs) with the Senhance® System.

Feb 10, 2020 04:15 pm ET

TransEnterix Announces Common Stock Purchase Agreement by Lincoln Park Capital Fund, LLC

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced today that it has entered into a common stock purchase agreement ("Purchase Agreement") with Lincoln Park Capital Fund, LLC ("Lincoln Park"), a Chicago-based institutional investor.

Jan 29, 2020 04:05 pm ET

TransEnterix Announces Kitakyushu General Hospital in Japan to Initiate a Senhance Digital Laparoscopy Program

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Kitakyushu General Hospital, a hospital in southwestern Japan, has entered into an agreement to lease and utilize a Senhance® System.

Jan 21, 2020 06:55 am ET

TransEnterix Announces Klinikum Esslingen to Initiate a Senhance Surgical System Program

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Klinikum Esslingen, a hospital in southern Germany close to Stuttgart, has entered into an agreement to lease and utilize a Senhance® System. The Senhance System has been installed at the hospital facility and cases are expected to begin shortly. This placement is one of the two placements referenced in the Company’s January 6, 2020 press release.

Jan 14, 2020 06:55 am ET

TransEnterix Announces Submission of 510(k) to FDA for First Machine Vision System in Robotic Surgery

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company filed a 510(k) submission with an Intelligent Surgical Unit (ISUTM)1 that is designed to enable machine vision capabilities on the SenhanceⓇ Surgical System.

Jan 08, 2020 06:55 am ET

TransEnterix Announces Ochsner Health System to Initiate Program with the Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Ochsner Health System has entered into an agreement to lease and utilize a Senhance® System that has been installed at the Ochsner Baptist* facility. This placement is one of the two placements referenced in the Company’s January 6, 2020 press release.

Jan 06, 2020 06:55 am ET

TransEnterix Provides 2019 Year End Corporate Update

Jan 03, 2020 06:55 am ET

TransEnterix to Present at the 38th Annual J. P. Morgan Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California. The presentation is scheduled to take place at 8:00 am Pacific Time (11:00 am Eastern Time), Thursday, January 16, 2020.

Jan 02, 2020 04:05 pm ET

TransEnterix, Inc. Announces Appointment of Interim Chief Financial Officer

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Brett Farabaugh has joined as interim Chief Financial Officer, effective January 2, 2020, replacing Joe Slattery who retired December 31, 2019, as previously announced.

Dec 11, 2019 11:30 am ET

TransEnterix Announces One-for-Thirteen Reverse Stock Split of its Common Stock

TransEnterix, Inc. (NYSE American: TRXC) today announced that, following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, the TransEnterix’s Board of Directors determined to effect a reverse stock split of TransEnterix’s common stock at a ratio of one-for-thirteen. The applicable Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, was filed with the Delaware Secretary of State today and will become effective at 5:00 p.m. Eastern Time on December 11, 201

Nov 26, 2019 06:55 am ET

TransEnterix, Inc. to Host Surgeon Panel Discussion and Senhance Technology Demonstration Event on Friday, December 6, 2019

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced it will host a surgeon panel discussion and Senhance technology demonstration via live webcast on Friday, December 6, 2019 from 11:00am to 12:00pm ET.

Nov 12, 2019 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2019

Nov 08, 2019 04:25 pm ET

TransEnterix Announces Repayment of Hercules Term Loan and Provides Update on AutoLap Transaction

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the repayment of all amounts owed under the loan agreement with Hercules Capital, Inc. (“Hercules”) (NYSE:HTGC) and provided an update on the AutoLap transaction.

Nov 08, 2019 04:20 pm ET

TransEnterix Board of Directors Appoints Anthony Fernando as President and Chief Executive Officer

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the Company’s Board of Directors has appointed Anthony Fernando, the Company’s current Chief Operating Officer and Chief Technology Officer, as President and Chief Executive Officer and a member of the Board of Directors, effective November 8, 2019. Mr. Fernando succeeds Todd Pope who is stepping down from his positions as President and Chief Executive Officer. Mr. Pope is committed to assisting with the tr

Oct 31, 2019 04:15 pm ET

TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 12, 2019

TransEnterix, Inc. (NYSEAmerican: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Tuesday, November 12, 2019. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Oct 30, 2019 06:18 am ET

TransEnterix Announces Plan for Reverse Stock Split

TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that its Board of Directors has approved a proposal, to be submitted to stockholders for approval at a Special Meeting of Stockholders anticipated to be held on December 18, 2019, to authorize the Board of Directors to effect a reverse stock split of the Company’s common stock. The reverse stock split proposal includes a proposed range between 1-for-10 and 1-for-40 shares of outstanding common stock. The final ra

Oct 17, 2019 04:30 pm ET

TransEnterix Provides a Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has agreed to amend the previously announced AutoLap System Sale Agreement. In addition, the Company announced that it has engaged J.P. Morgan Securities LLC to evaluate strategic alternatives while simultaneously re-directing its operational focus and implementing a restructuring plan to reduce operating expenses. The Company also announced that Joseph P. Slattery will retire from his position as c

Sep 11, 2019 04:05 pm ET

TransEnterix Senhance Microlaparoscopy 3 mm Instruments Portfolio Receives 2019 Innovations of the Year Award From SLS

TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the company’s Senhance Microlaparoscopy 3 mm instruments is a recipient of the 2019 Innovations of the Year award from the Society of Laparoendoscopic Surgeons (SLS). TransEnterix received the award at SLS’ Minimally Invasive Surgery Week 2019 (MISWeek 2019), September 4, in New Orleans, Louisiana. SLS recognizes the most innovative products of the past year that have a multidisciplinary application in

Sep 05, 2019 09:00 am ET

TransEnterix Announces Pricing of Public Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC) today announced that it priced a public offering of 28,000,000 shares of its common stock for gross proceeds of approximately $20.3 million, before deducting underwriting discounts and commissions and offering expenses payable by TransEnterix. In addition, the Company granted the underwriter a 30-day option to purchase approximately $3.0 million of additional shares of common stock. All of the shares in the offering are to be sold by TransEnterix. TransEnterix currently intends to use the net proceeds of this offering for general corporate purposes, inc

Sep 04, 2019 04:05 pm ET

TransEnterix Announces Proposed Public Offering of Common Stock

TransEnterix, Inc. (NYSE American: TRXC) today announced that it has commenced an underwritten public offering of shares of its common stock. TransEnterix intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. All of the shares in the offering are to be sold by TransEnterix.

Aug 21, 2019 06:55 am ET

TransEnterix to Present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference

TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference in Boston, MA. The presentation is scheduled to take place at 10:20 AM Eastern, Thursday, September 5, 2019.

Aug 07, 2019 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2019

Aug 01, 2019 07:41 am ET

TransEnterix Announces Broad Reimbursement Approval in Japan for Senhance Digital Laparoscopy System

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) expert review panel provided reimbursement for procedures performed with the Senhance Surgical System.

Jul 25, 2019 04:05 pm ET

TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 7, 2019

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 7, 2019. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Jul 10, 2019 12:48 pm ET

TransEnterix, Inc. Announces Sale of AutoLap Assets

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the sale of certain AutoLap® image-based laparoscope positioning system (AutoLap) assets to Great Belief International Limited (GBIL), for total proceeds of $47.0 million.

Jun 06, 2019 06:55 am ET

TransEnterix to Present at the Raymond James Life Sciences and MedTech Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Raymond James Life Sciences and Medtech Conference at The Lotte New York Palace in New York City. The presentation is scheduled to take place at 9:10 AM Eastern, Wednesday, June 19, 2019.

May 28, 2019 06:55 am ET

TransEnterix Announces Japanese Regulatory Approval of the Senhance Surgical System

May 09, 2019 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2019

May 07, 2019 06:55 am ET

TransEnterix to Present at the 2019 RBC Capital Markets Global Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 2019 RBC Capital Markets Global Healthcare Conference at The InterContinental New York Barclay in New York City. The presentation is scheduled to take place at 10:30 AM Eastern, Tuesday, May 21, 2019.

Apr 24, 2019 06:55 am ET

TransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 9, 2019

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release first quarter financial and operating results after the market closes on Thursday, May 9, 2019. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

Apr 17, 2019 08:30 am ET

Recent Analysis Shows TransEnterix, XOMA, Pixelworks, eGain, Mesa Laboratories, and Lantronix Market Influences — Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of TransEnterix, Inc. (NYSE:TRXC), XOMA Corporation (NASDAQ:XOMA), Pixelworks,...

Mar 28, 2019 06:55 am ET

TransEnterix to Showcase Digital Laparoscopy with the Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2019 Annual Meeting

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery (MIS), today announced it will host several events highlighting digital laparoscopy with the Senhance™ Surgical System–the first new abdominal robotic surgery platform to receive FDA clearance since 2000–at the 2019 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) April 3 – 6, 2019 in Baltimore, Maryland. Attendance at SAGES is expected to

Mar 19, 2019 08:42 am ET

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TransEnterix, Inc. (NYSE American: TRXC).

Feb 26, 2019 06:55 am ET

TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018

Feb 12, 2019 06:55 am ET

TransEnterix Schedules Fourth Quarter and Fiscal Year 2018 Financial and Operating Results Conference Call for February 26, 2019

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019. Todd M. Pope,President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will host a conference call to discuss these results starting at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.

Jan 15, 2019 06:55 am ET

TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System

Jan 07, 2019 06:55 am ET

TransEnterix Provides Corporate Update

Dec 20, 2018 12:06 am ET

TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at http://ir.transenterix.com/events.cfm. A replay of the webcast will be archived on the website for approximately 90 days.

Nov 15, 2018 06:55 am ET

TransEnterix Named to Deloitte’s Technology Fast 500

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced its naming to Deloitte’s 2018 Technology Fast 500TM, an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.

Nov 08, 2018 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2018

Oct 31, 2018 04:05 pm ET

TransEnterix to Present at the Stifel 2018 Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2018 Healthcare Conference at The Lotte New York Palace Hotel in New York City. The presentation is scheduled to take place at 12:30 PM Eastern, November 14, 2018.

Oct 24, 2018 07:30 am ET

Consolidated Research: 2018 Summary Expectations for Airgain, Vanda Pharmaceuticals, Westlake Chemical, TransEnterix, Versum Materials, and Triumph Group — Fundamental Analysis, Key Performance Indica

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Airgain, Inc. (NASDAQ:AIRG), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA),...

Oct 24, 2018 06:55 am ET

TransEnterix Schedules Third Quarter 2018 Financial and Operating Results Conference Call for November 8, 2018

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter 2018 financial and operating results after the market closes on Thursday, November 8, 2018. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

Oct 18, 2018 11:00 am ET

TransEnterix CEO, Todd Pope Named One of TIME Magazine’s 50 Most Influential People in Health Care 2018

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M. Pope, for being named to TIME Magazine's 50 Most Influential People in Health Care for 2018. In this inaugural list, Pope is highlighted for his role as one of those leaders whose work right now is transforming health care.

Oct 16, 2018 06:55 am ET

TransEnterix to Showcase First Digital Laparoscopic Surgical Platform, the Senhance Surgical System, at American College of Surgeons Clinical Congress 2018

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced demonstrations of its Senhance™ Surgical System at the American College of Surgeons (ACS) Clinical Congress 2018 at the Boston Convention & Visitors Center in Boston, MA, October 21 - 25.

Oct 11, 2018 06:55 am ET

TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received FDA 510(k) clearance for 3 millimeter diameter instruments, as well as additional 5 millimeter Senhance System instruments.

Oct 01, 2018 04:05 pm ET

TransEnterix Provides Corporate Update

Oct 01, 2018 06:55 am ET

TransEnterix Receives CE Mark Approval for Senhance Ultrasonic Instrument System

Sep 23, 2018 06:00 pm ET

TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical Surgery Technologies Ltd. (“MST”), an Israel medical technology company, in a cash and stock transaction with a total consideration, further described below. MST is a leader in the field of surgical technology, having developed a software-based image analytics platform powered by advanced v

Sep 20, 2018 04:30 pm ET

TransEnterix to Participate in Two Upcoming Healthcare Conferences

TransEnterix, Inc. (NYSE American:TRXC) announced today that TransEnterix will participate in two upcoming healthcare conferences:

Sep 06, 2018 06:55 am ET

TransEnterix Announces FDA 510(k) Submission for Senhance Ultrasonic Instrument System

Sep 04, 2018 04:05 pm ET

TransEnterix, Inc. Appoints Eric Smith as Chief Commercial Officer

Aug 22, 2018 06:55 am ET

TransEnterix to Present at the 13th Annual Wells Fargo Securities Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 13th Annual Wells Fargo Securities Healthcare Conference at The Westin Copley Place in Boston, Massachusetts. The presentation is scheduled to take place at 3:05 PM Eastern, September 6, 2018.

Aug 07, 2018 06:55 am ET

TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2018

Jul 24, 2018 06:55 am ET

TransEnterix Schedules Second Quarter 2018 Financial and Operating Results Conference Call for August 7, 2018

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release second quarter 2018 financial and operating results before the market opens on Tuesday, August 7, 2018. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will host a conference call to discuss these results starting at 8:30 am Eastern Time the same day. The call will be concurrently webcast.

Jul 02, 2018 06:55 am ET

TransEnterix Provides Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including the announcement of the sale of an additional Senhance system as well as preliminary unaudited revenue for the second quarter ended June 30, 2018.

Jun 25, 2018 06:55 am ET

TransEnterix, Inc. to Join the Russell 2000® Index

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the company will be added to the Russell 2000® Index at the conclusion of the Russell US Indexes annual reconstitution, effective after the U.S. market opens on June 25, 2018.

Jun 12, 2018 08:00 am ET

Analysis: Positioning to Benefit within Ally Financial, Huntsman, Synchrony Financial, Exelon, TransEnterix, and Centene — Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ally Financial Inc. (NYSE:ALLY), Huntsman Corporation (NYSE:HUN),...

Jun 07, 2018 04:05 pm ET

TransEnterix Announces FDA 510(k) Submission for 3mm Senhance Instruments

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company filed a FDA 510(k) submission for additional Senhance System instruments including 3 millimeter diameter instruments.

May 31, 2018 06:55 am ET

TransEnterix Announces LSU Health Completes Purchase of Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that LSU Health completed the purchase of the Company’s Senhance™ Surgical System. The Senhance has been installed at University Medical Center New Orleans (UMC New Orleans).

May 29, 2018 06:50 am ET

TransEnterix Announces FDA Clearance for Expanded Indications for Senhance Surgical System

May 23, 2018 04:05 pm ET

TransEnterix, Inc. Announces Loan Agreement with Hercules Capital

TransEnterix, Inc. (NYSE American: TRXC) (the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into a debt financing agreement with Hercules Capital, Inc., as administrative agent and collateral agent (“Hercules”), and the banks and financial institutions entering into the loan agreement, to provide the Company with up to $40.0 million in term loans.

May 08, 2018 04:05 pm ET

TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2018

Apr 24, 2018 06:55 am ET

TransEnterix Schedules First Quarter 2018 Financial and Operating Results Conference Call for May 8, 2018

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release first quarter 2018 financial and operating results after the market closes on Tuesday, May 8, 2018. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

Apr 04, 2018 05:15 pm ET

TransEnterix to Showcase Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2018 Annual Meeting

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, will showcase the Senhance™ Surgical System at the 16th World Congress of Endoscopic Surgery which is part of the 2018 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). The meeting will be held April 11-14, 2018 in Seattle, Washington. Attendance at SAGES is expected to include over 2,500 general, colon & rectal, endoscopic, pediatr

Mar 06, 2018 04:05 pm ET

TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2017

Feb 20, 2018 07:45 am ET

New Research: Key Drivers of Growth for Stag Industrial, Heartland Express, Antero Midstream Partners LP, TransEnterix, A-Mark Precious Metals, and Franklin Street Properties — Factors of Influence, M

NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stag Industrial, Inc. (NYSE:STAG), Heartland Express,...

Feb 20, 2018 06:55 am ET

TransEnterix Schedules Fourth Quarter and Fiscal Year 2017 Financial and Operating Results Conference Call for March 6, 2018

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2017 financial and operating results after the market closes on Tuesday, March 6, 2018. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

Feb 14, 2018 06:55 am ET

TransEnterix Announces FDA 510(k) Submission for Senhance Indication Expansion to More than Double Addressable Market in the U.S. and Provides Commercial Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has filed a FDA 510(k) submission to expand the indication for use of its Senhance™ Surgical System, and provided an update about commercial results thus far for the quarter ending March 31, 2018.

Feb 07, 2018 06:55 am ET

TransEnterix to Present at the RBC Capital Markets 2018 Global Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer will present at the RBC Capital Markets 2018 Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 2:05 PM Eastern, February 21, 2018.

Jan 31, 2018 06:55 am ET

TransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 7th Annual Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 1:30 PM Eastern, February 14, 2018.

Jan 08, 2018 06:55 am ET

TransEnterix Provides 2017 Year End Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today provided a year-end corporate update.

Dec 28, 2017 06:55 am ET

TransEnterix to Present at the 36th Annual J. P. Morgan Healthcare Conference

TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California. The presentation is scheduled to take place at 12:00 pm Pacific Time, Monday, January 8, 2018.

Dec 18, 2017 06:10 am ET

TransEnterix Announces Global SurgiBot System Agreement

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the Company has entered into an agreement with Great Belief International Limited (GBIL), to advance the SurgiBot System towards global commercialization. The SurgiBot System is the single-port, robotically enhanced laparoscopic surgical platform developed by TransEnterix.

Dec 04, 2017 08:30 am ET

Research Report Identifies TransEnterix, A-Mark Precious Metals, Franklin Street Properties, Stag Industrial, Heartland Express, and Antero Midstream Partners LP with Renewed Outlook — Fundamental Ana

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TransEnterix, Inc. (NYSE:TRXC), A-Mark Precious Metals,...

Nov 13, 2017 08:45 am ET

TransEnterix Announces Senhance US Sale Agreement With Florida Hospital

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Florida Hospital entered into an agreement to purchase the Company’s Senhance™ Surgical Robotic System.

Nov 09, 2017 04:05 pm ET

TransEnterix, Inc. Reports Operating Results for the Third Quarter 2017

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2017.

Nov 03, 2017 07:30 am ET

Recent Analysis Shows OncoSec Medical, Synchrony, DaVita, Capital One, TransEnterix, and Hess Market Influences – Renewed Outlook, Key Drivers of Growth

NEW YORK, Nov. 03, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OncoSec Medical Incorporated (NASDAQ:ONCS), Synchrony Financial...

Nov 02, 2017 04:05 pm ET

TransEnterix to Feature Senhance™ Surgical System at AAGL: Advancing Minimally Invasive Gynecology Worldwide

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it will exhibit and feature the Senhance™ Surgical Robotic System at the 46th AAGL Global Congress on Minimally Invasive Gynecologic Surgery (MIGS). The congress will be held November 12-16, 2017 in the Washington, DC area at the Gaylord National Resort and Convention Center at National Harbor.

Oct 31, 2017 06:55 am ET

TransEnterix to Present at the Stifel 2017 Healthcare Conference

TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2017 Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 5:00 PM Eastern Time on Tuesday, November 14, 2017.

Oct 23, 2017 06:54 am ET

TransEnterix Schedules Third Quarter 2017 Financial and Operating Results Conference Call for November 9, 2017

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release third quarter 2017 financial and operating results after the market closes on Thursday, November 9, 2017. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

Oct 13, 2017 05:00 pm ET

TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic System

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced the Company has received FDA 510(k) clearance for the Senhance™ Surgical Robotic System.

Oct 09, 2017 06:55 am ET

TransEnterix Announces Dismissal of Federal Securities Class Action

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the United States District Court for the Eastern District of North Carolina dismissed the securities class action suit filed in June 2016.

Jul 29, 2016 10:07 pm ET

TRANSENTERIX 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against TransEnter

NEW ORLEANS, July 29, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 1, 2016 to file lead plaintiff applications in a securities class action lawsuit against TransEnterix, Inc. (NYSE MKT:TRXC). Investor losses must relate to purchases of the Company’s securities between February 10, 2016 and May 10, 2016. This action is pending in the United States District Court for the Eastern District of North Carolina....

Jul 29, 2016 10:17 am ET

TRXC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving TransEnterix, Inc. and a Lead Plaintiff Deadline of August 1, 2016

NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of North Carolina on behalf of investors who purchased TransEnterix, Inc. (NYSE MKT:TRXC) securities between February 10, 2016 and May 10, 2016....

Jul 27, 2016 09:47 am ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of TransEnterix, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 – TRXC

NEW YORK, July 27, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:...

Jul 24, 2016 09:00 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TransEnterix, Inc. of Class Action Lawsuit and Upcoming Deadline – TRXC

NEW YORK, July 24, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TransEnterix Inc. (“TransEnterix” or the “Company”) (NYSE:TRXC) and certain of its officers. The class action, filed in United States District Court, Middle District of North Carolina, and docketed under 16-cv-599, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired TransEnterix securities between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants ...

Jul 18, 2016 06:27 pm ET

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TransEnterix, Inc. - TRXC

NEW YORK, July 18, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of TransEnterix, Inc. securities (NYSE:TRXC) from February 10, 2016 through May 10, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for TransEnterix investors under the federal securities laws....

Jul 15, 2016 02:57 pm ET

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of TransEnterix, Inc. Of Upcoming Deadline

WILMINGTON, Del., July 15, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:...

Jul 12, 2016 11:11 am ET

TRXC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving TransEnterix, Inc. and a Lead Plaintiff Deadline of August 1, 2016

NEW YORK, July 12, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of North Carolina on behalf of investors who purchased TransEnterix, Inc. (NYSE MKT: TRXC) securities between February 10, 2016 and May 10, 2016.

Jul 11, 2016 10:28 am ET

Kessler Topaz Meltzer & Check, LLP Reminds TransEnterix, Inc. Shareholders of Important Deadline in Class Action Lawsuit -- TRXC

The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed in the United States District Court for the Eastern District of North Carolina against TransEnterix, Inc. (NYSE: TRXC)...

Jul 01, 2016 11:07 pm ET

TRANSENTERIX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Again

NEW ORLEANS, July 1, 2016 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 1, 2016 to file lead plaintiff applications in a securities class action lawsuit against TransEnterix, Inc. (NYSE MKT: TRXC), if they purchased the Company's securities between February 10, 2016 and May 10, 2016, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of North Carolina.

Jul 01, 2016 06:29 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TransEnterix, Inc. of Class Action Lawsuit and Upcoming Deadline - TRXC

NEW YORK, July 1, 2016 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against TransEnterix Inc. ("TransEnterix" or the "Company") (NYSE: TRXC) and certain of its officers. The class action, filed in United States District Court, Middle District of North Carolina, and docketed under 16-cv-599, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired TransEnterix securities between February 10, 2016 and May 10, 2016, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for

Jun 29, 2016 04:24 pm ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving TransEnterix, Inc. and a Lead Plaintiff Deadline of August 1, 2016 – TRXC

NEW YORK, June 29, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of North Carolina on behalf of investors who purchased TransEnterix, Inc. (NYSE:TRXC) securities between February 10, 2016 and May 10, 2016....

Jun 24, 2016 03:59 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TransEnterix, Inc. of Class Action Lawsuit and Upcoming Deadline – TRXC

NEW YORK, June 24, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TransEnterix Inc. (“TransEnterix” or the “Company”) (NYSE:TRXC) and certain of its officers. The class action, filed in United States District Court, Middle District of North Carolina, and docketed under 16-cv-599, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired TransEnterix securities between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants...

Jun 24, 2016 12:19 pm ET

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of TransEnterix, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 – TRXC

NEW YORK, June 24, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:...

Jun 21, 2016 09:45 am ET

Lawsuit for Investors in shares of TransEnterix Inc (NYSEMKT:TRXC) announced by Shareholders Foundation

SAN DIEGO, June 21, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in North Carolina on behalf of certain purchasers of shares of TransEnterix Inc (NYSEMKT:TRXC) over alleged Securities Laws Violations by TransEnterix Inc The lawsuit seeks to recover damages for certain (NYSEMKT:TRXC) investors....

Jun 17, 2016 10:07 pm ET

TRANSENTERIX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Again

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 1, 2016 to file lead plaintiff applications in a securities class action lawsuit against...

Jun 16, 2016 10:00 am ET

Shareholder Class Action Filed Against TransEnterix, Inc. - TRXC

RADNOR, Pa., June 16, 2016 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against TransEnterix, Inc. (NYSE: TRXC) ("TransEnterix" or the "Company") on behalf of purchasers of the Company's securities between February 10, 2016 and May 10, 2016, inclusive (the "Class Period").

Jun 15, 2016 10:35 am ET

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of TransEnterix, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 -- TRXC

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of TransEnterix, Inc. ("TransEnterix" or the "Company") (NYSE MKT: TRXC) between February 10, 2016 and...

Jun 14, 2016 10:11 am ET

Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws

MERION, Pa., June 14, 2016 /PRNewswire/ -- The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:

Jun 13, 2016 10:10 am ET

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against TransEnterix, Inc.

On June 2, 2016, a class action lawsuit was filed in the United States District Court for the Eastern District of North Carolina against TransEnterix, Inc. (NYSE: TRXC). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 10, 2016 through May 10, 2016.

Jun 10, 2016 10:48 am ET

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving TransEnterix, Inc. and a Lead Plaintiff Deadline of August 1, 2016 – TRXC

NEW YORK, June 10, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of North Carolina on behalf of investors who purchased TransEnterix, Inc. (NYSE:TRXC) securities between February 10, 2016 and May 10, 2016....

Jun 09, 2016 06:30 pm ET

IMPORTANT TRANSENTERIX, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been commenced on behalf of shareholders of TransEnterix, I

NEW YORK, June 09, 2016 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE:TRXC) in the United States District Court for the Eastern District of North Carolina on behalf of purchasers of TransEnterix common stock between February 10, 2016 through May 10, 2016, inclusive (the “Class Period”)....

Jun 09, 2016 04:38 pm ET

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against TransEnterix, Inc.

...

Jun 09, 2016 04:08 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against TransEnterix, Inc. and Certain Officers – TRXC

NEW YORK, June 09, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TransEnterix Inc. (“TransEnterix” or the “Company”) (NYSE:TRXC) and certain of its officers. The class action, filed in United States District Court, Middle District of North Carolina, and docketed under 16-cv-599, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired TransEnterix securities between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”). This class action seeks to recover damages against Defendan...

Jun 06, 2016 12:01 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of TransEnterix, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 – TRXC

NEW YORK, June 06, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:...

Jun 04, 2016 12:03 am ET

Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; Ability Inc., Plantronics, Inc., TransEnterix, Inc. and Big Lots Inc.; Encourages Investors to Contact the Firm for Infor

SAN DIEGO, June 3, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential claims against Ability Inc., Plantronics, Inc., TransEnterix, Inc. and Big Lots Inc., as detailed below:

Jun 03, 2016 11:30 pm ET

IMPORTANT SHAREHOLDER NOTICE: Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In TransEnterix, Inc.

STEVENSON, Md., June 03, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of North Carolina on behalf of purchasers of TransEnterix, Inc. (NYSE MKT:TRXC) (“TransEnterix” or the “Company”) common stock during the period between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”). Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 1, 2016...

Jun 03, 2016 10:07 pm ET

TRANSENTERIX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Again

NEW ORLEANS, June 03, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 1, 2016 to file lead plaintiff applications in a securities class action lawsuit against TransEnterix, Inc. (NYSE:TRXC), if they purchased the Company’s securities between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of North Carolina....

Jun 03, 2016 09:00 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against TransEnterix, Inc. (TRXC)

NEW YORK, June 03, 2016 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE:TRXC) in the United States District Court for the Eastern District of North Carolina on behalf of purchasers of TransEnterix common stock between February 10, 2016 through May 10, 2016, inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”)....

Jun 03, 2016 11:00 am ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TransEntrix, Inc. (TRX) and Lead Plaintiff Deadline: August 1, 2016

NEW YORK, June 3, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against TransEntrix, Inc. ("TransEntrix" or "the Company") (NYSE MKT: TRXC ). The class action has been filed in the United States District Court, Eastern District of North Carolina, on behalf of a class consisting of all persons or entities who purchased TransEntrix securities during the period between February 10, 2016 and May 10, 2016 inclusive (the "Class Period").

Jun 02, 2016 06:29 pm ET

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against TransEnterix, Inc.

SAN DIEGO, June 2, 2016 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP ("Robbins Geller") (http://www.rgrdlaw.com/cases/transenterix/) today announced that a class action has been commenced on behalf of purchasers of TransEnterix, Inc. ("TransEnterix") (NYSE MKT:TRXC) common stock during the period between February 10, 2016 and May 10, 2016, inclusive (the "Class Period"). This action was filed in the Eastern District of North Carolina and is captioned Bankley v. TransEnterix, Inc., et al., No. 16-cv-00313-BR.

May 09, 2016 09:47 pm ET

Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.

NEW YORK, May 9, 2016 /PRNewswire/ --

Apr 21, 2016 01:17 pm ET

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of TransEnterix, Inc. (TRXC)

NEW YORK, April 21, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of TransEnterix, Inc. (TRXC) ("TransEnterix" or the "Company") (NYSE: TRXC). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at [email protected] or 212-697-6484.

Apr 20, 2016 11:25 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of TransEnterix - TRXC

NEW YORK, April 20, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TransEnterix, Inc. ("TransEnterix" or the "Company") (NYSEMKT: TRXC). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

You are here

(:TRXC)

Business Focus: N/A